17 results
6-K
OBSVF
ObsEva SA
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
exceptions within the control of Kissei. While many of these materials may be obtained by more than one supplier, restrictions resulting from
6-K
OBSVF
ObsEva SA
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
of these materials may be obtained by more than one supplier, restrictions resulting from the coronavirus pandemic in the regions our third-party
DRS
EX-10
OBSVF
ObsEva SA
14 Oct 16
Draft registration statement
12:00am
supplier based on the pharmaceutical industry standard, Kissei shall use Commercially Reasonable Efforts to start the process to have a back-up supplier … be reasonable (the “Transition Period”). Kissei shall cooperate with ObsEva to find a new supplier and make it be able to manufacture Compound within
F-1
EX-10.3
ydgp04zj6e1
30 Dec 16
Registration statement (foreign)
12:00am
6-K
EX-99.1
qvu14a3r2d9
7 Aug 19
Current report (foreign)
7:21am
20-F
anyk1 phio22ai
21 Apr 17
Annual report (foreign)
12:00am
DRS
yvbzekf0x38
14 Oct 16
Draft registration statement
12:00am
F-1
94l rvtqgmlm8zge
30 Dec 16
Registration statement (foreign)
12:00am
424B5
87ae4haix
8 Sep 20
Prospectus supplement for primary offering
7:31am
- Prev
- 1
- Next